<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39330317</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>29</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2308-3425</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>25</Day></PubDate></JournalIssue><Title>Journal of cardiovascular development and disease</Title><ISOAbbreviation>J Cardiovasc Dev Dis</ISOAbbreviation></Journal><ArticleTitle>The Role of Cardiac Magnetic Resonance in mRNA COVID-19 Vaccine-Related Myopericarditis: An Evolutive Case Series.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">259</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcdd11090259</ELocationID><Abstract><AbstractText>Numerous cases of myocarditis related to mRNA vaccines for COVID-19 have recently been described, usually in young men. Long-term evolutive cardiac magnetic resonance imaging (CMR) data are lacking. We describe four consecutive cases of COVID-19 vaccine-induced myocarditis. The pathological findings of cardiac magnetic resonance confirmed the diagnosis in the acute phase, showing edema, as well as pericardial enhancement, with light pericardial effusion and late gadolinium enhancement (LGE), predominantly in the inferolateral wall. These cases highlight the unique value of cardiac magnetic resonance in patients with suspected myocarditis induced by COVID-19 RNAm vaccines as a tool to confirm the diagnosis, avoiding other invasive techniques, as well as for the long-term follow-up of patients. Our iterative CMR imaging demonstrated frequent long-term LGE persistence.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Feltes</LastName><ForeName>Gisela</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Hospital Universitario de Torrejón, 28850 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario Vithas Arturo Soria, 28043 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, 28670 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sánchez Sánchez</LastName><ForeName>Violeta</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hospital Universitario Vithas Arturo Soria, 28043 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, 28670 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pérez-David</LastName><ForeName>Esther</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, 28670 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario La Paz, 28046 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno-Hurtrez</LastName><ForeName>José Luis</ForeName><Initials>JL</Initials><AffiliationInfo><Affiliation>Hospital Universitario Moncloa, 28027 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiménez</LastName><ForeName>Juan Delgado</ForeName><Initials>JD</Initials><Identifier Source="ORCID">0000-0002-5401-8324</Identifier><AffiliationInfo><Affiliation>Hospital Universitario Vithas Arturo Soria, 28043 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario 12 de Octubre, 28041 Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Núñez-Gil</LastName><ForeName>Iván J</ForeName><Initials>IJ</Initials><Identifier Source="ORCID">0000-0002-1779-3102</Identifier><AffiliationInfo><Affiliation>Hospital Universitario de Torrejón, 28850 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Universitario Vithas Arturo Soria, 28043 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Villaviciosa de Odón, 28670 Madrid, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hospital Clinico San Carlos, 28040 Madrid, Spain.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>25</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Cardiovasc Dev Dis</MedlineTA><NlmUniqueID>101651414</NlmUniqueID><ISSNLinking>2308-3425</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">cardiac magnetic resonance</Keyword><Keyword MajorTopicYN="N">case series</Keyword><Keyword MajorTopicYN="N">myocarditis</Keyword><Keyword MajorTopicYN="N">vaccines</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>16</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>16</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>27</Day><Hour>9</Hour><Minute>33</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>25</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39330317</ArticleId><ArticleId IdType="pmc">PMC11432323</ArticleId><ArticleId IdType="doi">10.3390/jcdd11090259</ArticleId><ArticleId IdType="pii">jcdd11090259</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Gargano J., Wallace M., Hadler S., Langley G., Su J., Oster M., Broder K., Gee J., Weintraub E., Shimabukuro T., et al. Use of mRNA COVID-19 Vaccine after Reports of Myocarditis among Vaccine Recipients: Update from the Advisory Committee on Immunization Practices—United States, June 2021. MMWR Morb. Mortal Wkly. Rep. 2021;70:977–982. doi: 10.15585/mmwr.mm7027e2.</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7027e2</ArticleId><ArticleId IdType="pmc">PMC8312754</ArticleId><ArticleId IdType="pubmed">34237049</ArticleId></ArticleIdList></Reference><Reference><Citation>Nune A., Durkowski V., Pillay S.S., Barman B., Elwell H., Bora K., Bilgrami S., Mahmood S., Babajan N., Venkatachalam S., et al. New-Onset Rheumatic Immune-Mediated Inflammatory Diseases Following SARS-CoV-2 Vaccinations until May 2023: A Systematic Review. Vaccines. 2023;11:1571. doi: 10.3390/vaccines11101571.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11101571</ArticleId><ArticleId IdType="pmc">PMC10610967</ArticleId><ArticleId IdType="pubmed">37896974</ArticleId></ArticleIdList></Reference><Reference><Citation>Buoninfante A., Andeweg A., Genov G., Cavaleri M. Myocarditis associated with COVID-19 vaccination. Vaccines. 2024;9:122. doi: 10.1038/s41541-024-00893-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41541-024-00893-1</ArticleId><ArticleId IdType="pmc">PMC11213864</ArticleId><ArticleId IdType="pubmed">38942751</ArticleId></ArticleIdList></Reference><Reference><Citation>Salehzadeh F., Pourfarzi F., Ataei S. The Impact of Colchicine on COVID-19 patients: A Clinical Trial Study. Mediterr. J. Rheumatol. 2022;33:232–236. doi: 10.31138/mjr.33.2.232.</Citation><ArticleIdList><ArticleId IdType="doi">10.31138/mjr.33.2.232</ArticleId><ArticleId IdType="pmc">PMC9450200</ArticleId><ArticleId IdType="pubmed">36128202</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshiwy K., Amin G.E.E., Farres M.N., Samir R., Allam M.F. The role of colchicine in the management of COVID-19: A Meta-analysis. BMC Pulm. Med. 2024;24:190. doi: 10.1186/s12890-024-03001-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12890-024-03001-0</ArticleId><ArticleId IdType="pmc">PMC11031948</ArticleId><ArticleId IdType="pubmed">38641775</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeo S.Z.J., Ho C.L. COVID-19 mRNA vaccine-related myocarditis: A PRISMA systematic review, imaging approach and differential diagnoses. Radiol. Case Rep. 2023;19:1008–1019. doi: 10.1016/j.radcr.2023.11.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.radcr.2023.11.070</ArticleId><ArticleId IdType="pmc">PMC10788373</ArticleId><ArticleId IdType="pubmed">38226053</ArticleId></ArticleIdList></Reference><Reference><Citation>Valore L., Junker T., Heilmann E., Zuern C.S., Streif M., Drexler B., Arranto C., Halter J.P., Berger C.T. Case report: mRNA-1273 COVID-19 vaccine-associated myopericarditis: Successful treatment and re-exposure with colchicine. Front. Cardiovasc. Med. 2023;10:1135848. doi: 10.3389/fcvm.2023.1135848.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcvm.2023.1135848</ArticleId><ArticleId IdType="pmc">PMC10149711</ArticleId><ArticleId IdType="pubmed">37139123</ArticleId></ArticleIdList></Reference><Reference><Citation>Caredda G., Bassareo P.P., Cau R., Mannelli L., Suri J.S., Saba L. Emerging Role of Cardiac Magnetic Resonance Imaging in Diagnosing Myocarditis: A Blunder or the Way to Get the Problem Sorted? J. Thorac. Imaging. 2022;37:W12–W27. doi: 10.1097/RTI.0000000000000634.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RTI.0000000000000634</ArticleId><ArticleId IdType="pubmed">35191862</ArticleId></ArticleIdList></Reference><Reference><Citation>Aviv Y., Shiyovich A., Plakht Y., Witberg G., Weissman M., Shafir G., Kornowski R., Hamdan A. Cardiac Magnetic Resonance Imaging in COVID-19 Vaccine-Associated Myocarditis Compared With Classical Myocarditis. JACC Adv. 2023;2:100726. doi: 10.1016/j.jacadv.2023.100726.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacadv.2023.100726</ArticleId><ArticleId IdType="pmc">PMC11198221</ArticleId><ArticleId IdType="pubmed">38938491</ArticleId></ArticleIdList></Reference><Reference><Citation>Fronza M., Thavendiranathan P., Chan V., Karur G.R., Udell J.A., Wald R.M., Hong R., Hanneman K. Myocardial Injury Pattern at MRI in COVID-19 Vaccine-Associated Myocarditis. Radiology. 2022;304:553–562. doi: 10.1148/radiol.212559.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.212559</ArticleId><ArticleId IdType="pmc">PMC8856022</ArticleId><ArticleId IdType="pubmed">35166587</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozkurt B., Kamat I., Hotez P.J. Myocarditis with COVID-19 mRNA Vaccines. Circulation. 2021;144:471–484. doi: 10.1161/CIRCULATIONAHA.121.056135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCULATIONAHA.121.056135</ArticleId><ArticleId IdType="pmc">PMC8340726</ArticleId><ArticleId IdType="pubmed">34281357</ArticleId></ArticleIdList></Reference><Reference><Citation>Núñez-Gil I.J., Feltes G., Viana-Llamas M.C., Raposeiras-Roubin S., Romero R., Alfonso-Rodríguez E., Uribarri A., Santoro F., Becerra-Muñoz V., Pepe M., et al. Post-COVID-19 Symptoms and Heart Disease: Incidence, Prognostic Factors, Outcomes and Vaccination: Results from a Multi-Center International Prospective Registry (HOPE 2) J. Clin. Med. 2023;12:706. doi: 10.3390/jcm12020706.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm12020706</ArticleId><ArticleId IdType="pmc">PMC9863454</ArticleId><ArticleId IdType="pubmed">36675633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianchi F.P., Rizzi D., Daleno A., Stefanizzi P., Migliore G., Tafuri S. Assessing the temporal and cause-effect relationship between myocarditis and mRNA COVID-19 vaccines. A retrospective observational study. Int. J. Infect. Dis. 2024;141:106960. doi: 10.1016/j.ijid.2024.02.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijid.2024.02.003</ArticleId><ArticleId IdType="pubmed">38365084</ArticleId></ArticleIdList></Reference><Reference><Citation>Adler Y., Charron P., Imazio M., Badano L., Barón-Esquivias G., Bogaert J., Brucato A., Gueret P., Klingel K., Lionis C., et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases: The Task Force for the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology (ESC)Endorsed by: The European Association for Cardio-Thoracic Surgery (EACTS) Eur. Heart J. 2015;36:2921–2964.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7539677</ArticleId><ArticleId IdType="pubmed">26320112</ArticleId></ArticleIdList></Reference><Reference><Citation>Maron B.J., Udelson J.E., Bonow R.O., Nishimura R.A., Ackerman M.J., Estes N.A., 3rd, Cooper L.T., Jr., Link M.S., Maron M.S., American Heart Association Electrocardiography and Arrhythmias Committee of Council on Clinical Cardiology et al. Eligibility and Disqualification Recommendations for Competitive Athletes with Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. Circulation. 2015;132:e273–e280.</Citation><ArticleIdList><ArticleId IdType="pubmed">26621644</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel Y., Louis D., Atalay M., Agarwal S., Shah N. Cardiovascular magnetic resonance findings in young adult patients with acute myocarditis following mRNA COVID-19 vaccination: A case series. J. Cardiovasc. Magn. Reson. 2021;23:101. doi: 10.1186/s12968-021-00795-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12968-021-00795-4</ArticleId><ArticleId IdType="pmc">PMC8425992</ArticleId><ArticleId IdType="pubmed">34496880</ArticleId></ArticleIdList></Reference><Reference><Citation>Gräni C., Eichhorn C., Bière L., Murthy V.L., Agarwal V., Kaneko K., Cuddy S., Aghayev A., Steigner M., Blankstein R., et al. Prognostic Value of Cardiac Magnetic Resonance Tissue Characterization in Risk Stratifying Patients with Suspected Myocarditis. J. Am. Coll. Card. 2017;70:1964–1976. doi: 10.1016/j.jacc.2017.08.050.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jacc.2017.08.050</ArticleId><ArticleId IdType="pmc">PMC6506846</ArticleId><ArticleId IdType="pubmed">29025553</ArticleId></ArticleIdList></Reference><Reference><Citation>Talib N., Fronza M., Marschner C.A., Thavendiranathan P., Karur G.R., Hanneman K. Cardiovascular magnetic resonance imaging and clinical follow-up in patients with clinically suspected myocarditis after COVID-19 vaccination. J. Cardiovasc. Magn. Reson. 2024;26:101036. doi: 10.1016/j.jocmr.2024.101036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocmr.2024.101036</ArticleId><ArticleId IdType="pmc">PMC11004989</ArticleId><ArticleId IdType="pubmed">38479457</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>